Home » News » One Health debate » Page 2

One Health debate

On Thursday, 28 February 2019, the ‘One Health’ debate will take place in The Hague. This debate is the conclusion of the Castellum research programme: a public-private partnership aimed at developing vaccines against zoonoses.

The Castellum programme focused on research into new vaccines for animals to prevent the introduction and spread of zoonoses. The goal of the public-private partnership was to make at least one vaccine available for the market, and this goal was achieved. The project has resulted in a new vaccine against Rift Valley fever virus (RVFV). Wageningen Bioveterinary Research (WBVR) has developed and tested the vaccine for safety and efficacy at its laboratory and animal facilities, where it is possible to work safely with zoonotic infectious diseases.

New innovation program

In 2019, the Netherlands Centre for One Health (NCOH) is launching a new Innovation Programme that is funded by the Top Sector Lifesciences and Health. The new programme is also based on a public-private partnership in the field of One Health. The One Health debate on 28 February 2019 will focus on scientific, organisational and administrative insights that emerged from Castellum programme. Relevant themes for the new Innovation Programme will also be discussed. Learn more about Castellum.

More News

dr. Rory de Vries wins Beijerinck Virology Premium for young virologists

Rory de Vries (born 1982) is receiving the premium for his research on the human body’s defences against respiratory viral infections, and for his ability to communicate his knowledge of virology and infectious diseases to a wide audience. Rory de Vries is a post-doctoral researcher at Erasmus MC in Rotterdam.

More

Antibiotic resistance in the Netherlands under control

Contamination with resistant bacteria in patients admitted to Dutch hospitals does not result in higher mortality than contamination by non-resistant bacteria. Although the problem of antibiotic resistance in the Netherlands currently seems manageable, it is important to remain vigilant in view of the ever-changing epidemiology of resistant bacteria, according to Wouter Rottier, who was awarded... More

Volunteering to become ill to help researchers

Radboudumc has combined its research into controlled human infection models to create a new program: the Radboudumc Controlled Human Infection Models (RCHIM). By studying the interaction between pathogens and humans under controlled conditions, researchers can improve their understanding of the underlying disease mechanisms. This understanding contributes to a more targeted development of medicines and vaccines... More

Twitter account NCOH: @ncohnl

In January 2016, NCOH’s own bilingual Twitter account, @ncohnl, was registered. With investigators in the field of one health as a primary target group, via this Twitter account relevant developments in the context of one health are highlighted.

More